Yujiao Zhang

Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Impact of RUNX1 mutations at distinct sites on the clinical characteristics and prognosis of patients with acute myeloid leukemia.

Impact of RUNX1 mutations at distinct sites on the clinical characteristics and prognosis of patients with acute myeloid leukemia.

Journal: BMC cancer

Published: January 02, 2026

ALDH3A2-mediated fatty acid synthesis induces ferroptosis and AML drug resistance.

ALDH3A2-mediated fatty acid synthesis induces ferroptosis and AML drug resistance.

Journal: iScience

Published: July 25, 2025

Platelet count and sleep quality in immune thrombocytopenia: correlation with 5-hydroxytryptamine and therapeutic implications of platelet-5-HT-melatonin axis dysregulation.

Platelet count and sleep quality in immune thrombocytopenia: correlation with 5-hydroxytryptamine and therapeutic implications of platelet-5-HT-melatonin axis dysregulation.

Journal: Frontiers in neurology

Published: June 20, 2025

The clinical utility of metagenomic next-generation sequencing in the management of fever in patients with hematological disorders.

The clinical utility of metagenomic next-generation sequencing in the management of fever in patients with hematological disorders.

Journal: Nagoya journal of medical science

Published: June 17, 2025

Clinical efficacy and safety of venetoclax combined with hypomethylating agents in relapsed high-risk acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation.

Clinical efficacy and safety of venetoclax combined with hypomethylating agents in relapsed high-risk acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation.

Journal: Frontiers in medicine

Published: June 03, 2025

Dynamics of measurable residual disease for risk stratification and guiding allogeneic transplant in acute myeloid leukaemia patients with myelodysplasia-related mutations in first remission.

Dynamics of measurable residual disease for risk stratification and guiding allogeneic transplant in acute myeloid leukaemia patients with myelodysplasia-related mutations in first remission.

Journal: British journal of haematology

Published: August 08, 2024

Influence of genetic co-mutation on chemotherapeutic outcome in NPM1-mutated and FLT3-ITD wild-type AML patients.

Influence of genetic co-mutation on chemotherapeutic outcome in NPM1-mutated and FLT3-ITD wild-type AML patients.

Journal: Cancer medicine

Published: May 11, 2024

Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD+ acute myeloid leukemia by inhibiting β-catenin activity via the PP2A-GSK3β axis.

Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD+ acute myeloid leukemia by inhibiting β-catenin activity via the PP2A-GSK3β axis.

Journal: Cell communication and signaling : CCS

Published: May 01, 2024

Impact of different CEBPA mutations on therapeutic outcome in acute myeloid leukemia.

Impact of different CEBPA mutations on therapeutic outcome in acute myeloid leukemia.

Journal: Annals of hematology

Published: November 22, 2023

Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia.

Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia.

Journal: BMC cancer

Published: May 12, 2023

Avatrombopag for the salvage treatment of platelet transfusion refractoriness.

Avatrombopag for the salvage treatment of platelet transfusion refractoriness.

Journal: Therapeutic advances in hematology

Published: March 21, 2023

Thrombopoietin promotes megakaryopoiesis via protecting bone marrow endothelial function in patients undergoing chemotherapy for hematological malignancies

Thrombopoietin promotes megakaryopoiesis via protecting bone marrow endothelial function in patients undergoing chemotherapy for hematological malignancies

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Published: September 08, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026